Sagittarius EU Project

🤝 𝐈𝐟 𝐲𝐨𝐮 𝐡𝐚𝐯𝐞 𝐭𝐡𝐞 𝐫𝐢𝐠𝐡𝐭 𝐜𝐡𝐚𝐫𝐚𝐜𝐭𝐞𝐫𝐢𝐬𝐭𝐢𝐜𝐬, e.g. you still haven’t had colon cancer surgery or you have had it for less than 3 days, you may consider taking part in the trial. 👉 The patient involved in the SAGITTARIUS study has a 50% chance of being prescribed a treatment that may be more suitable for them, because it may be more effective or because it may avoid side effects from potentially unnecessary therapies. In the other 50% of cases, they would still receive the best available therapy. 👩⚕️👨⚕️ In any case, every patient will always be under SAGITTARIUS doctors' careful and constant control. 💕 Every SAGITTARIUS patient will also contribute to the success of the project and generate new knowledge that may be used to improve post-operative treatment for patients with colon cancer across the European Union. ℹ️ 𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧, 𝐩𝐥𝐞𝐚𝐬𝐞 𝐜𝐨𝐧𝐭𝐚𝐜𝐭 𝐭𝐡𝐞 𝐜𝐞𝐧𝐭𝐫𝐞 𝐨𝐟 𝐫𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐧𝐞𝐚𝐫𝐞𝐬𝐭 𝐲𝐨𝐮: - 🇮🇹 Consulta "La rete dei centri clinici": https://lnkd.in/djmpVq3y - 🇪🇸 Consulta "La red clínica": https://lnkd.in/dZvdVBbQ - 🇩🇪 Siehe "Das klinische Netzwerk der SAGITTARIUS-Studie": https://lnkd.in/d-JWZc73 - 🇬🇧 Check "The clinical network": https://lnkd.in/dPQmhjjs #ColonCancer #SagittariusEU #SagittariusProject #coloncancercare #EUCancerMission #CancerResearch #CRC #LiquidBiopsy #ClinicalTrial #PersonalisedMedicine #CancerTreatment IFOM Fondazione AIRC per la Ricerca sul Cancro ETS Università Bocconi Hospital del Mar Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin Ospedale Niguarda di Milano Fondazione Oncologia Niguarda Onlus Cogentech Società Benefit srl European Health and Digital Executive Agency (HaDEA) European Commission

💡 Join this pivotal event dedicated to enhancing colorectal cancer screening and achieving 90% coverage by 2025. The SAGITTARIUS project is proud to highlight the importance of initiatives like the 5th DiCE CRC Screening Summit! The agenda features a lineup of experts, including the inspiring Zorana Maravic, CEO of Digestive Cancers Europe and a valued member of our consortium. 📅 When: 5 December, 9:00 AM CET 📍 Where: Online 🔗 Register here: https://lnkd.in/eD6wfNbs See you there! #SAGITTARIUSProject #5thCRCSummit #ColorectalCancer #CancerScreening #EarlyDetection #CancerAwareness Tomislav Sokol European People's Party Iris Lansdorp-Vogelaar Erasmus MC Agnieszka Kinsner-Ovaskainen European Commission Marianna Vitaloni, Ph.D. Manon Spaander Lisa Wilde Bowel Cancer UK Yasemin Hirst University of Central Lancashire Isabel Mosquera Metcalfe IARC - International Agency for Research on Cancer / World Health Organization David Weller The University of Edinburgh

Siamo orgogliosi di annunciare l’avvio dello studio clinico SAGITTARIUS con i primi 6 pazienti reclutati! Coordinato da IFOM e finanziato da Horizon Europe, SAGITTARIUS segna l’inizio di una rivoluzione nel trattamento del cancro al colon. Con i primi 6 pazienti già reclutati, lo studio utilizza la biopsia liquida per personalizzare le terapie post-operatorie, migliorando l’efficacia dei trattamenti e riducendo la tossicità della chemioterapia. "Questo è solo l'inizio di un percorso che potrebbe cambiare la vita di milioni di pazienti" ha commentato Silvia Marsoni, coordinatrice scientifica di IFOM. Il progetto coinvolge Fondazione AIRC per la Ricerca sul Cancro ETS e 7 partner in 5 Paesi europei, con un focus su Italia, Spagna e Germania. Per maggiori informazioni visita Sagittarius EU Project Lo studio raccontato da ANSA: https://lnkd.in/dxfq8sti #IFOM #SAGITTARIUS #HorizonEurope

🎉 Exciting news from SAGITTARIUS! We are delighted to announce that patient recruitment has officially begun, with our first patients now enrolled in the study! Over the coming months, clinical sites across Italy, Germany, and Spain will gradually open, with more patients to be included in this groundbreaking trial. This marks a significant milestone in the SAGITTARIUS clinical trial, which aims to revolutionise colon cancer treatment. We are testing the use of liquid biopsy, an innovative tool that could personalise post-surgery treatments for patients with high-risk stage II and operable stage III colon cancer. 👉 Read more about the news here: https://lnkd.in/dR7aJ5gw Stay tuned for further updates! 🌐 Website: https://lnkd.in/ehy55__6 🔗 Follow us: https://lnkd.in/dcEgaAzr #EUCancerMission #CancerResearch #ColonCancer #CRC #LiquidBiopsy #ClinicalTrial #SagittariusProject #SagittariusEU #PersonalisedMedicine #CancerTreatment IFOM Fondazione AIRC per la Ricerca sul Cancro ETS Università Bocconi Hospital del Mar Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin Ospedale Niguarda di Milano Ospedale Niguarda di Milano European Health and Digital Executive Agency (HaDEA) European Commission

Colorectal cancer remains one of Europe’s most pressing health challenges, but together, we can make a difference. As part of our commitment to improving outcomes for high-risk colon cancer patients, the SAGITTARIUS project is proud to highlight the importance of initiatives like the 5th DiCE CRC Screening Summit. Created by Digestive Cancers Europe, a SAGITTARIUS Consortium Partner. This pivotal event is dedicated to enhancing colorectal cancer screening and achieving 90% coverage by 2025. 📅 When: 5 December, 9:00 AM CET 📍 Where: Online Join experts, healthcare professionals, and policymakers to discuss key strategies for: ✅ Expanding access to screening programs ✅ Personalising screening approaches ✅ Mobilising communities for early detection 🎯 Together, we can build a future where early detection and equitable care save lives. 🔗 Register here: https://lnkd.in/eD6wfNbs #SAGITTARIUSProject #5thCRCSummit #ColorectalCancer #CancerScreening #EarlyDetection #CancerAwareness Digestive Cancers Europe Erasmus MC University of Latvia (Latvijas Universitāte) European Commission A.O.U. Città della Salute e della Scienza di Torino Privatklinik Confraternität | PremiQaMed Group The University of Edinburgh IARC - International Agency for Research on Cancer / World Health Organization University of Central Lancashire Bowel Cancer UK Amsterdam UMC

🎙️Meet Ricardo Pietrobon, CEO of SporeData Inc., a company driven by a multidisciplinary team with diverse expertise and a shared dedication to excellence. Positioned at the intersection of data science and clinical research, SporeData enhances health analytics in partnership with leading institutions across the USA and Europe. With deep expertise in data integration, management, and analysis of clinical trials, SporeData leverages advanced data science models to design and execute innovative clinical studies and health policy research, delivering results via an Agile workflow. In the SAGITTARIUS project, SporeData will lead the integrated data analysis and collaborate on cost-effectiveness assessments. They will also contribute to the final analysis, combining clinical, health economics, and quality of life outcomes to develop comprehensive clinical utility metrics. 🤔Would you like to know more? The next video will be coming soon! Please SHARE, LIKE, and VISIT our website https://lnkd.in/ehy55__6 ! #SAGITTARIUSEU #SAGITTARIUSProject #CRC #ColonCancerCare #HorizonEU #EUCancerMission Hospital del Mar Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin IFOM European Commission European Parliament EU Science, Research and Innovation Cogentech Società Benefit srl European Health and Digital Executive Agency (HaDEA)

The Diagnostics & Treatment Cluster, supported by Horizon Europe’s Cancer Mission, unites 12 innovative projects across Europe to develop clinical trials focused on optimizing cancer diagnosis and treatment. We’re proud that the LIVERATION project is part of this effort, aiming to transform liver cancer care. Through this collaboration, we’re collectively striving to improve patient outcomes and bring hope to those facing refractory cancers. Stay tuned to learn more about our journey within this impactful network! 🔗www.liveration.eu  🔗https://lnkd.in/d4CjyBFf #HorizonEurope #CancerMission #Liveration #LiverationEU #HorizonEU Alexandra Dima  European Health and Digital Executive Agency (HaDEA) EU Health and Food Safety WHO Regional Office for Europe EASL the home of Hepatology UEG - United European Gastroenterology ESMO - European Society for Medical Oncology International Liver Cancer Association (ILCA) IARC - International Agency for Research on Cancer / World Health Organization  Gustave Roussy DE-ESCALATE Project IMPORTANT EU Project LEGATO Project PragmaTIL PRIME-ROSE Sagittarius EU Project SALVOVAR STREXIT 2 Project  Dimitris Mavridis Angel Alonso Emilio González-González Patricia Sánchez-Velázquez Carlos Fuste Fernando Burdio David Alcantara, PhD Benedetto Ielpo Carola Orrego Villagrán Miriam Rol García, Ph.D. European Liver Patients' Association - ELPA Carina Dantas Natália Machado

🎙️ The voice of patients is critical in shaping clinical trials. This is why the SAGITTARIUS Project is collaborating with Digestive Cancers Europe (DiCE) to ensure that patients' perspectives are at the heart of everything we do. Meet Marianna Vitaloni, Ph.D. , a passionate Patient Advocate and Medical & Scientific Project Manager at DiCE. In this video, Marianna shares how DiCE works closely with SAGITTARIUS to incorporate patient views into clinical trial design, aiming to improve both the quality of life and care for those facing colon cancer. Want to learn more about how this partnership is driving change? Watch the video to hear Marianna’s insights on this essential collaboration. The SAGITTARIUS Project is testing the use of liquid biopsy to guide personalized post-surgery treatment aiming to improve patient care and outcomes. 🤔 Curious about what’s next? Stay tuned—the next video is coming soon! Please SHARE, LIKE, and VISIT our website https://lnkd.in/ehy55__6 #SAGITTARIUSEU #SAGITTARIUSProject #ColonCancerCare #HorizonEU #EUCancerMission Università Bocconi Hospital del Mar Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin IFOM European Commission European Parliament EU Science, Research and Innovation Cogentech Società Benefit srl European Health and Digital Executive Agency (HaDEA)

Clinical trials, or interventional studies, are conducted with volunteers. They aim to test in humans the safety and efficacy of new methods of prevention, screening, diagnosis, or treatment of a disease, which were already tested in preclinical tests (conducted on animals, cells or computer models). Clinical trials are carefully designed and reviewed and must be approved before starting. Biomedical clinical trials are divided into 4 stages: - Phase I studies are conducted with a small group of volunteers, to evaluate the safe dosage range of a drug. - Phase II studies test treatments that were found to be safe in Phase I on a larger group of human subjects. They aim to assess the intervention's efficacy and detect possible adverse effects. - Phase III studies, conducted on interventions that performed well in Phase II, are the final stage before approving the new treatment. They are carried out with hundreds or thousands of volunteers in many regions and countries. - After Phase III, a country can approve the new medical approach for clinical use. However, it is still monitored in the Phase IV study, or pharmacovigilance, to identify possible rare side effects over a longer period. SAGITTARIUS is a Phase III clinical trial that may transform colon cancer treatment by using liquid biopsy, an innovative approach in precision medicine, to tailor post-surgical treatment for patients with locoregional colon cancer (high-risk stage II and operable stage III). To find out more about the SAGITTARIUS project, stay tuned and visit the website: https://lnkd.in/ehy55__6 #SagittariusEU #SagittariusProject #CRC #ColonCancerCare #HorizonEU #EUCancerMission IFOM Fondazione AIRC per la Ricerca sul Cancro ETS Università Bocconi Hospital del Mar Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin European Commission European Health and Digital Executive Agency (HaDEA) Fondazione Ospedale Niguarda Ospedale Niguarda di Milano

🎙️Meet Prof. Aleksandra Torbica, a professor at the Department of Social and Political Sciences at Università Bocconi, in Milan. Università Bocconi is a leading European university of global standing in social sciences. It includes the CERGAS, the Centre for Research on Health and Social Care Management, which promotes scientific research on healthcare management at national and international levels. For 40 years, CERGAS has influenced Italy's National Health Service and reshaped views on healthcare. As a leading multidisciplinary research centre, CERGAS advances knowledge in healthcare management, health policy, economics, and social organisations, driving innovation and impact in the field. Within SAGITTARIUS, Università Bocconi (CERGAS) is a Consortium Member and will be conducting the cost-effectiveness analysis. 🤔Would you like to know more? The next video will be coming soon! Please SHARE, LIKE, and VISIT our website https://lnkd.in/d_ES8Xnz! #SAGITTARIUSEU #SAGITTARIUSProject # CRC # ColonCancerCare #HorizonEU #EUCancerMission Hospital del Mar Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin IFOM European Commission European Parliament EU Science, Research and Innovation Cogentech Società Benefit srl European Health and Digital Executive Agency (HaDEA)